Data as of Sep 02
| -0.49 / -2.47%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 18.75, with a high estimate of 21.00 and a low estimate of 16.50. The median estimate represents a -2.90% decrease from the last price of 19.31.
The current consensus among 2 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.